NDC 42254-134 Lyrica
View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 42254 - Rebel Distributors Corp
- 42254-134 - Lyrica
Product Characteristics
WHITE (C48325)
Product Packages
NDC Code 42254-134-90
Package Description: 90 CAPSULE in 1 BOTTLE
Product Details
What is NDC 42254-134?
What are the uses for Lyrica?
Which are Lyrica UNII Codes?
The UNII codes for the active ingredients in this product are:
- PREGABALIN (UNII: 55JG375S6M)
- PREGABALIN (UNII: 55JG375S6M) (Active Moiety)
Which are Lyrica Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- STARCH, CORN (UNII: O8232NY3SJ)
- TALC (UNII: 7SEV7J4R1U)
- GELATIN (UNII: 2G86QN327L)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- SODIUM LAURYL SULFATE (UNII: 368GB5141J)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
- SHELLAC (UNII: 46N107B71O)
- FERROSOFERRIC OXIDE (UNII: XM0M87F357)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)
What is the NDC to RxNorm Crosswalk for Lyrica?
- RxCUI: 577127 - pregabalin 225 MG Oral Capsule
- RxCUI: 607024 - Lyrica 225 MG Oral Capsule
- RxCUI: 607024 - pregabalin 225 MG Oral Capsule [Lyrica]
* Please review the disclaimer below.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".